Researchers at the Duke Human Vaccine Institute are one step closer to creating a vaccine for HIV, or human immunodeficiency virus, which can lead to AIDS (acquired immunodeficiency syndrome).

DURHAM, N.C. (WTVD) -- Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine, successfully developing a vaccine candidate that ...

Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells along an evolutionary pathway to become broadly neutralizing antibodies.

During fiscal year 2024, it reported $466 million in licensing revenue. The Duke University Human Vaccine Institute was awarded $7 million from the federal health agencies to conduct clinical trials ...

This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the ...

One strategy antiabortion advocates may increasingly rely upon as they attempt to block medication abortion from reaching ...